Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154893626> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W3154893626 abstract "COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease progression include lymphopenia, elevated proinflammatory cytokines and chemokines, accumulation of macrophages and neutrophils in lungs, immune dysregulation, cytokine storms, acute respiratory distress syndrome (ARDS), etc. Development of vaccines to severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome coronavirus (MERS-CoV), and other coronavirus has been difficult to create due to vaccine induced enhanced disease responses in animal models. Multiple betacoronaviruses including SARS-CoV-2 and SARS-CoV-1 expand cellular tropism by infecting some phagocytic cells (immature macrophages and dendritic cells) via antibody bound Fc receptor uptake of virus. Antibody-dependent enhancement (ADE) may be involved in the clinical observation of increased severity of symptoms associated with early high levels of SARS-CoV-2 antibodies in patients. Infants with multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 may also have ADE caused by maternally acquired SARS-CoV-2 antibodies bound to mast cells. ADE risks associated with SARS-CoV-2 has implications for COVID-19 and MIS-C treatments, B-cell vaccines, SARS-CoV-2 antibody therapy, and convalescent plasma therapy for patients. SARS-CoV-2 antibodies bound to mast cells may be involved in MIS-C and multisystem inflammatory syndrome in adults (MIS-A) following initial COVID-19 infection. SARS-CoV-2 antibodies bound to Fc receptors on macrophages and mast cells may represent two different mechanisms for ADE in patients. These two different ADE risks have possible implications for SARS-CoV-2 B-cell vaccines for subsets of populations based on age, cross-reactive antibodies, variabilities in antibody levels over time, and pregnancy. These models place increased emphasis on the importance of developing safe SARS-CoV-2 T cell vaccines that are not dependent upon antibodies." @default.
- W3154893626 created "2021-04-26" @default.
- W3154893626 creator A5023468724 @default.
- W3154893626 date "2021-02-01" @default.
- W3154893626 modified "2023-09-23" @default.
- W3154893626 title "Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies" @default.
- W3154893626 hasPublicationYear "2021" @default.
- W3154893626 type Work @default.
- W3154893626 sameAs 3154893626 @default.
- W3154893626 citedByCount "0" @default.
- W3154893626 crossrefType "journal-article" @default.
- W3154893626 hasAuthorship W3154893626A5023468724 @default.
- W3154893626 hasConcept C126322002 @default.
- W3154893626 hasConcept C140704245 @default.
- W3154893626 hasConcept C142724271 @default.
- W3154893626 hasConcept C159047783 @default.
- W3154893626 hasConcept C159654299 @default.
- W3154893626 hasConcept C164027704 @default.
- W3154893626 hasConcept C196594336 @default.
- W3154893626 hasConcept C203014093 @default.
- W3154893626 hasConcept C2522874641 @default.
- W3154893626 hasConcept C2776090121 @default.
- W3154893626 hasConcept C2776348555 @default.
- W3154893626 hasConcept C2776914184 @default.
- W3154893626 hasConcept C2777648638 @default.
- W3154893626 hasConcept C2777714996 @default.
- W3154893626 hasConcept C2777910003 @default.
- W3154893626 hasConcept C2779134260 @default.
- W3154893626 hasConcept C2779559532 @default.
- W3154893626 hasConcept C2780850621 @default.
- W3154893626 hasConcept C3008058167 @default.
- W3154893626 hasConcept C3875195 @default.
- W3154893626 hasConcept C524204448 @default.
- W3154893626 hasConcept C71924100 @default.
- W3154893626 hasConcept C8891405 @default.
- W3154893626 hasConceptScore W3154893626C126322002 @default.
- W3154893626 hasConceptScore W3154893626C140704245 @default.
- W3154893626 hasConceptScore W3154893626C142724271 @default.
- W3154893626 hasConceptScore W3154893626C159047783 @default.
- W3154893626 hasConceptScore W3154893626C159654299 @default.
- W3154893626 hasConceptScore W3154893626C164027704 @default.
- W3154893626 hasConceptScore W3154893626C196594336 @default.
- W3154893626 hasConceptScore W3154893626C203014093 @default.
- W3154893626 hasConceptScore W3154893626C2522874641 @default.
- W3154893626 hasConceptScore W3154893626C2776090121 @default.
- W3154893626 hasConceptScore W3154893626C2776348555 @default.
- W3154893626 hasConceptScore W3154893626C2776914184 @default.
- W3154893626 hasConceptScore W3154893626C2777648638 @default.
- W3154893626 hasConceptScore W3154893626C2777714996 @default.
- W3154893626 hasConceptScore W3154893626C2777910003 @default.
- W3154893626 hasConceptScore W3154893626C2779134260 @default.
- W3154893626 hasConceptScore W3154893626C2779559532 @default.
- W3154893626 hasConceptScore W3154893626C2780850621 @default.
- W3154893626 hasConceptScore W3154893626C3008058167 @default.
- W3154893626 hasConceptScore W3154893626C3875195 @default.
- W3154893626 hasConceptScore W3154893626C524204448 @default.
- W3154893626 hasConceptScore W3154893626C71924100 @default.
- W3154893626 hasConceptScore W3154893626C8891405 @default.
- W3154893626 hasOpenAccess W3154893626 @default.
- W3154893626 hasRelatedWork W1589412181 @default.
- W3154893626 hasRelatedWork W2025080738 @default.
- W3154893626 hasRelatedWork W261295809 @default.
- W3154893626 hasRelatedWork W3017074092 @default.
- W3154893626 hasRelatedWork W3024454674 @default.
- W3154893626 hasRelatedWork W3033015248 @default.
- W3154893626 hasRelatedWork W3037718428 @default.
- W3154893626 hasRelatedWork W3081829885 @default.
- W3154893626 hasRelatedWork W3082341874 @default.
- W3154893626 hasRelatedWork W3097119905 @default.
- W3154893626 hasRelatedWork W3098118792 @default.
- W3154893626 hasRelatedWork W3110811441 @default.
- W3154893626 hasRelatedWork W3115992232 @default.
- W3154893626 hasRelatedWork W3116442774 @default.
- W3154893626 hasRelatedWork W3126183222 @default.
- W3154893626 hasRelatedWork W3127086530 @default.
- W3154893626 hasRelatedWork W3132048909 @default.
- W3154893626 hasRelatedWork W3172356334 @default.
- W3154893626 hasRelatedWork W3192678061 @default.
- W3154893626 hasRelatedWork W3193191879 @default.
- W3154893626 isParatext "false" @default.
- W3154893626 isRetracted "false" @default.
- W3154893626 magId "3154893626" @default.
- W3154893626 workType "article" @default.